Esophageal Cancer

Latest News

Investigators will continue to assess the efficacy and safety of lenvatinib plus pembrolizumab and chemotherapy as frontline treatment for patients with metastatic esophageal squamous cell carcinoma in part 2 of the LEAP-014 study.
Lenvatinib Combo Demonstrates Safety, Activity in Metastatic ESCC

October 23rd 2023

Investigators will continue to assess the efficacy and safety of lenvatinib plus pembrolizumab and chemotherapy as frontline treatment for patients with metastatic esophageal squamous cell carcinoma in part 2 of the LEAP-014 study.

Data from the NeoRes II trial caution against routinely delaying surgery for more than 6 weeks after patients with resectable locally advanced esophageal cancer receive neoadjuvant chemoradiotherapy.
Longer Surgery Delay After CRT Does Not Improve Esophageal Cancer Responses

September 23rd 2023

Patients with complete lymph node response, partial lymph node response, or negative lymph node response were less likely to experience recurrence and increased survival in esophageal adenocarcinoma.
Lymph Node Classification May Help Prognosticate in Esophageal Cancer

August 26th 2023

Investigators report that patients with advanced or metastatic esophageal squamous cell carcinoma had superior overall survival benefit following treatment with tislelizumab/chemotherapy vs placebo/chemotherapy.
Tislelizumab/Chemo Yields Survival Benefit in Advanced Esophageal Cancer

April 25th 2023

Video Interviews
Podcasts

More News